Increases in resistant infections from 2019 to 2020 seen for carbapenem-resistant Acinetobacter, antifungal-resistant Candida auris
Pediatric Antibiotic Prescribing Dropped During Pandemic
Decrease in antibiotic prescriptions in pediatric primary care driven by reduced volume of visits for respiratory tract infections
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Current Guidelines May Lead to Antibiotic Overuse for SARS-CoV-2 Pneumonia
Bacterial superinfection at time of intubation occurred in <25 percent of patients; reduced antibiotic use seen with bronchoalveolar lavage-based management versus current guidelines
Antibiotic Dispensing Decreased After COVID-19 Restrictions
36 percent reduction seen in antibiotic dispensing after COVID-19 restrictions; large reduction found in antibiotics for RTIs
Respiratory Virus Detections Decreased During COVID-19
Monthly antibiotic prescriptions for respiratory tract infections decreased 79 percent during pandemic period
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia